Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recombinant growth hormone improves growth and adult height in patients with maternal inactivating GNAS mutations.
Ertl DA, de Nanclares GP, Jüppner H, Hanna P, Pagnano A, Pereda A, Rothenbuhler A, Del Sindaco G, Ruiz-Cuevas P, Audrain C, Escribano A, Berkenou J, Gleiss A, Mantovani G, Linglart A. Ertl DA, et al. Among authors: pagnano a. Eur J Endocrinol. 2023 Jul 20;189(1):123-131. doi: 10.1093/ejendo/lvad085. Eur J Endocrinol. 2023. PMID: 37440712 Free PMC article.
Growth patterns and outcomes of growth hormone therapy in patients with acrodysostosis.
Ertl DA, Mantovani G, de Nanclares GP, Elli FM, Pereda A, Pagnano A, Sanchis A, Cueto-Gonzalez AM, Berrade S, León MC, Rothenbuhler A, Audrain C, Berkenou J, Knight N, Dolman K, Gleiss A, Argente J, Linglart A. Ertl DA, et al. Among authors: pagnano a. J Endocrinol Invest. 2023 Aug;46(8):1673-1684. doi: 10.1007/s40618-023-02026-2. Epub 2023 Feb 7. J Endocrinol Invest. 2023. PMID: 36749450
Application of calcium-to-phosphorus (Ca/P) ratio in the diagnosis of pseudohypoparathyroidism: another piece in the puzzle of diagnosis of Ca-P metabolism disorders.
De Vincentis S, Del Sindaco G, Pagnano A, Brigante G, Moretti A, Zirilli L, Rochira V, Simoni M, Mantovani G, Madeo B. De Vincentis S, et al. Among authors: pagnano a. Front Endocrinol (Lausanne). 2023 Oct 3;14:1268704. doi: 10.3389/fendo.2023.1268704. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37854194 Free PMC article.
C-Cell Hyperplasia and Cystic Papillary Thyroid Carcinoma in a Patient with Type 1B Pseudohypoparathyroidism and Hypercalcitoninaemia: Case Report and Review of the Literature.
Ferrari D, Pandozzi C, Filice A, Nardi C, Cozzolino A, Melcarne R, Giacomelli L, Biffoni M, Di Gioia C, Merenda E, Del Sindaco G, Pagnano A, Pofi R, Giannetta E. Ferrari D, et al. Among authors: pagnano a. J Clin Med. 2023 Dec 6;12(24):7525. doi: 10.3390/jcm12247525. J Clin Med. 2023. PMID: 38137593 Free PMC article. Review.
Recurrence in acromegaly: two tertiary centers experience and review of the literature.
Cremaschi A, Sala E, Lavezzi E, Carosi G, Del Sindaco G, Mangone A, Mungari R, Pagnano A, Indirli R, Ferrante E, Mazziotti G, Locatelli M, Lasio G, Arosio M, Lania AG, Mantovani G. Cremaschi A, et al. Among authors: pagnano a. J Endocrinol Invest. 2024 Sep;47(9):2269-2277. doi: 10.1007/s40618-024-02321-6. Epub 2024 Mar 19. J Endocrinol Invest. 2024. PMID: 38502285 Free PMC article. Review.
Targeted silencing of GNAS in a human model of osteoprogenitor cells results in the deregulation of the osteogenic differentiation program.
Elli FM, Mattinzoli D, Ikehata M, Bagnaresi F, Maffini MA, Del Sindaco G, Pagnano A, Lucca C, Messa P, Arosio M, Castellano G, Alfieri CM, Mantovani G. Elli FM, et al. Among authors: pagnano a. Front Endocrinol (Lausanne). 2024 May 17;15:1296886. doi: 10.3389/fendo.2024.1296886. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38828417 Free PMC article.
Gamma knife radiosurgery in patients with Nelson's syndrome.
Losa M, Detomas M, Bailo M, Barzaghi LR, Albano L, Piloni M, Pagnano A, Pedone E, Mortini P. Losa M, et al. Among authors: pagnano a. J Endocrinol Invest. 2021 Oct;44(10):2243-2251. doi: 10.1007/s40618-021-01531-6. Epub 2021 Feb 20. J Endocrinol Invest. 2021. PMID: 33611756
19 results